Skip to main navigation menu Skip to main content Skip to site footer
Español (España) | English
Editorial
Revistas/Journals
Salud, Ciencia y Tecnología Metaverse Basic and Applied Research Data & Metadata Interdisciplinary Rehabilitation Salud, Ciencia y Tecnología - Serie de Conferencias Community and Interculturality in Dialogue Seminars in Medical Writing and Education Health Leadership and Quality of Life Gamification and Augmented Reality Southern perspective / Perspectiva austral
Home
Issue
Current Issue Archives Special Issue
About
About the Journal Editorial Team Privacy Statement Digital preservation policy Contact
Author Guidelines
Guidelines for authors Peer Review Process Open Access Policy and Copyright Ethical aspects Anti-plagiarism policy Crossmark policy page
Indexing
×
Español (España) | English
Editorial

Salud, Ciencia y Tecnología Metaverse Basic and Applied Research Data & Metadata Interdisciplinary Rehabilitation Salud, Ciencia y Tecnología - Serie de Conferencias Community and Interculturality in Dialogue Seminars in Medical Writing and Education Health Leadership and Quality of Life Gamification and Augmented Reality Southern perspective / Perspectiva austral
Home

Current Issue Archives Special Issue

About the Journal Editorial Team Privacy Statement Digital preservation policy Contact

Guidelines for authors Peer Review Process Open Access Policy and Copyright Ethical aspects Anti-plagiarism policy Crossmark policy page
Indexing
Review
Published: 2024-02-16
DOI: https://doi.org/10.56294/saludcyt2024733

Emerging biomarkers in gestational diabetes: perspectives for improving diagnosis and prognoses

By
Andrea Belén Miranda Sánchez ,
Andrea Belén Miranda Sánchez

Universidad Técnica de Ambato, Facultad Ciencias de la Salud, Carrera de Laboratorio Clínico. Ambato, Ecuador

Search this author on:

PubMed | Google Scholar
Álvaro Paul Moina Veloz ,
Álvaro Paul Moina Veloz

Universidad Técnica de Ambato, Facultad Ciencias de la Salud, Carrera de Laboratorio Clínico. Ambato, Ecuador

Search this author on:

PubMed | Google Scholar

Abstract

Gestational diabetes mellitus is a pathology suffered by one in seven pregnant women worldwide, in which carbohydrate metabolism is altered, that is, glucose intolerance occurs. It is recognized for the first time in pregnancy since these adaptations occur with the objective of providing an adequate amount of glucose to the fetus for its development. They are related to risk factors such as age, diet, lack of physical activity, among others, and can cause fetal macrosomia, neonatal jaundice, and cardiorespiratory complications. In the mother, it is diagnosed through different blood glucose tests such as the oral glucose tolerance test, O'Sullivan test, however currently new biomarkers have been implemented for an early prognosis such as IL-27, a protein retinol transporter 4, maternal fetuin A, high sensitivity C-reactive protein and molecular biomarkers, but more studies are required so that these biochemical markers can be standardized by an organization.

Keywords:

Gestational diabetes,
hyperglycemia,
biomarkers,

How to Cite

1.
Miranda Sánchez AB, Moina Veloz Álvaro P. Emerging biomarkers in gestational diabetes: perspectives for improving diagnosis and prognoses. Salud, Ciencia y Tecnología [Internet]. 2024 Feb. 16 [cited 2024 Jul. 27];4:733. Available from: https://revista.saludcyt.ar/ojs/index.php/sct/article/view/733

Copyright Notice

The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.

Article metrics

Google scholar: See link

Metrics

Metrics Loading ...

Vol. 4 (2024)
See full issue

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.